Clinical Trials Market - Statistics & Insights

The global clinical trials market is valued at USD 76.7 billion in 2024, encompassing Phase I–IV studies across pharmaceuticals, biologics, medical devices, and digital therapeutics. North America leads with a 48% market share, driven by the U.S.’s strong biopharma pipeline, advanced research infrastructure, and favorable NIH funding. Europe follows, supported by robust clinical networks under EMA oversight. Asia Pacific is the fastest-growing region, fueled by efficient patient recruitment, lower trial costs, and government incentives in India, China, and South Korea.